Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
|Videos|January 15, 2019
Treating Immunocompromised Patients with Hepatitis B
Author(s)Contagion® Editorial Staff
Kenneth Sherman, MD, discusses hepatitis B infections in immunocompromised patients and what clinicians should expect to see in the future for hepatitis B treatment.
Advertisement
In a presentation at ID Week 2018, Kenneth Sherman, MD, Gould Professor of Medicine at the University of Cincinnati College of Medicine, discussed hepatitis B infections in immunocompromised patients and what clinicians should expect to see in the future for hepatitis B treatment.
Interview transcript: (modified slightly for readability)Contagion®: What should clinicians know about treating immunocompromised patients with hepatitis B?
Dr. Sherman: Immunocompromised patients with hepatitis B are at risk for increased rates of disease progression, related to the presence of hepatitis B. Those patients have higher levels of ALT which reflects higher levels of inflammation which leads to higher rates of hepatic fibrosis.
Therefore, at any given time in the course of the disease, those patients will end up with more likelihood of having eventually cirrhosis and all of the complications that accompany cirrhosis. Often these may be unrecognized until the patient presents with decompensated liver disease
Advertisement
Related to this article
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement
Trending on Contagion Live
1
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
2
Measles Update: October 2, 2026
3
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
4
New IDSA/ESCMID S aureus Bacteremia Consensus Statements: a Risk Stratification Framework
5